Usefulness of L-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma

Journal of Neurosurgery

Volumn 103, Issue 3, 2005, Pages 498-507

  Nariai, Tadashi ^a   Tanaka, Yoji ^b   Wakimoto, Hiroaki ^b   Aoyagi, Masaru ^b   Tamaki, Masashi ^b   Ishiwata, Kiichi ^b   Senda, Michio ^b   Ishii, Kenji ^b   Hirakawa, Kimiyoshi ^b   Ohno, Kikuo ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NONE

Author keywords

Amino acid tracer; Astrocytoma; Glioblastoma multiforme; Oligodendroglioma; Positron emission tomography

Indexed keywords

METHIONINE DERIVATIVE; METHIONINE METHYL C 11; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; METHIONINE;

ADULT; ARTICLE; BIOLOGICAL MONITORING; BRAIN; CANCER CHEMOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; BRAIN TUMOR; CLINICAL TRIAL; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PREDICTION AND FORECASTING; SCINTISCANNING; SURVIVAL;

BRAIN NEOPLASMS; GLIOMA; HUMANS; METHIONINE; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 27244439231     PISSN: 00223085     EISSN: 00223085     Source Type: Journal    
DOI: 10.3171/jns.2005.103.3.0498     Document Type: Article

References (41)

1. Ardekani BA, Braun M, Hutton BF, Kanno I, Iida H: A fully automatic multimodality image registration algorithm. J Comput Assist Tomogr 19:615-623, 1995
2. Becherer A, Karanikas G, Szabo M, Zettinig G, Asenbaum S, Marosi C, et al: Brain tumour imaging with PET: a comparison between [18F]fluorodopa and [11C]methionine. Eur J Nucl Med Mol Imaging 30:1561-1567, 2003
3. Buckner JC, Gesme D Jr, O'Fallon JR, Hammack JE, Stafford S, Brown PD, et al: Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. J Clin Oncol 21:251-255, 2003
4. Coleman RE: Value of FDG-PET scanning in management of lung cancer. Lancet 359:1361-1362, 2002
5. De Witte O, Goldberg I, Wikler D, Rorive S, Damhaut P, Monclus M, et al: Positron emission tomography with injection of methionine as a prognostic factor in glioma. J Neurosurg 95:746-750, 2001
6. Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, et al: [11C]L-methionine uptake in gliomas. Neurosurgery 25:720-728, 1989
7. Derlon JM, Chapon F, Noel MH, Khouri S, Benali K, Petit-Taboue MC, et al: Non-invasive grading of oligodendrogliomas: correlation between in vivo metabolic pattern and histopathology. Eur J Nucl Med 27:778-787, 2000
8. Giese A, Westphal M: Glioma invasion in the central nervous system. Neurosurgery 39:235-252, 1996
9. Gould MK, Maclean CC, Kuschner WG, Rydzak CE, Owens DK: Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 285:914-924, 2001
10. Heiss P, Mayer S, Herz M, Wester HJ, Schwaiger M, Senekowitsch-Schmidtke R: Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo. J Nucl Med 40:1367-1373, 1999
11. Herholz K, Holzer T, Bauer B, Schroder R, Voges J, Ernestus RI, et al: 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316-1322, 1998
12. Holzer T: The in vivo metabolic pattern of low-grade brain gliomas: a positron emission tomographic study using f-18-fluorodeoxyglucose and c-11-L-methylmethionine. Neurosurgery 42:1200-1201, 1998
13. Ingvar MC, Maeder P, Sokoloff L, Smith CB: Effects of ageing on local rates of cerebral protein synthesis in Sprague-Dawley rats. Brain 108:155-170, 1985
14. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, et al: Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissues be measured in vivo? J Nucl Med 34:1936-1943, 1993
15. Ishiwata K, Vaalburg W, Elsinga PH, Paans AM, Woldring MG: Metabolic studies with L-[1-14C]tyrosine for the investigation of a kinetic model to measure protein synthesis rates with PET. J Nucl Med 29:524-529, 1988
16. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA: Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 42:432-445, 2001
17. Kim S, Chung JK, Im SH, Jeong JM, Lee DS, Kim DG, et al: 11C-methionine PET as a prognostic marker in patients with glioma: comparison with (18)F-FDG PET. Eur J Nucl Med Mol Imaging 32:52-59, 2004
18. Kristof RA, Neuloh G, Hans V, Deckert M, Urbach H, Schlegel U, et al: Combined surgery, radiation, and PCV chemotherapy for astrocytomas compared to oligodendrogliomas and oligoastrocytomas WHO grade III. J Neurooncol 59:231-237, 2002
19. Kubota K: From tumor biology to clinical PET: a review of positron emission tomography (PET) in oncology. Ann Nucl Med 15:471-486, 2001
20. Levin VA, Maor MH, Thall PF, Yung WK, Bruner J, Sawaya R, et al: Phase II study of accelerated fractionation radiation therapy with carboplatin followed by vincristine chemotherapy for the treatment of glioblastoma multiforme. Int J Radiat Oncol Biol Phys 33:357-364, 1995
21. Loeffler JS, Alexander E III, Shea WM, Wen PY, Fine HA, Kooy HM, et al: Radiosurgery as part of the initial management of patients with malignant gliomas. J Clin Oncol 10:1379-1385, 1992
22. Mineura K, Sasajima T, Suda Y, Kowada M, Shishido F, Uemura K: Amino acid study of cerebral gliomas using positron emission tomography - analysis of (11C-methyl)-L-methionine uptake index. Neurol Med Chir 30:997-1002, 1990
23. Nagano N, Sasaki H, Aoyagi M, Hirakawa K: Invasion of experimental rat brain tumor: early morphological changes following microinjection of C6 glioma cells. Acta Neuropathol 86:117-125, 1993
24. Nariai T, Senda M, Ishii K, Maehara T, Wakabayashi S, Toyama H, et al: Three-dimensional imaging of cortical structure, function and glioma for tumor resection. J Nucl Med 38:1563-1568, 1997
25. Nelson DF, Curran WJ Jr, Scott C, Nelson JS, Weinstein AS, Ahmad K, et al: Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma - possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302. Int J Radiat Oncol Biol Phys 25:193-207, 1993
26. Nwokedi EC, DiBiase SJ, Jabbour S, Herman J, Amin P, Chin LS: Gamma knife stereotactic radiosurgery for patients with glioblastoma multiforme. Neurosurgery 50:41-47, 2002
27. Ogawa T, Inugami A, Hatazawa J, Kanno I, Murakami M, Yasui N, et al: Clinical positron emission tomography for brain tumors: comparison of fluorodeoxyglucose F 18 and L-methyl-11C-methionine. AJNR 17:345-353, 1996
28. Ogawa T, Shishido F, Kanno I, Inugami A, Fujita H, Murakami M, et al: Cerebral glioma: evaluation with methionine PET. Radiology 186:45-53, 1993
29. Ribom D, Eriksson A, Hartman M, Engler H, Nilsson A, Langstrom B, et al: Positron emission tomography (11)C-methionine and survival in patients with low-grade gliomas. Cancer 92:1541-1549, 2001
30. Salazar OM, VanHoutte PJ, Bennett JM, Rubin P, Wheeler KT: High-dose radiation therapy with low-dose (pulsed) BCNU in malignant gliomas: an Eastern Cooperative Oncology Group (ECOG) report. Int J Radiat Oncol Biol Phys 8:915-919, 1982
31. Schiff D: Dramatic response to chemotherapy in oligodendroglial gliomatosis cerebri. Neurology 61:425, 2003
32. Senda M: Mapping cortical functions using PET activation technique, in Sugishita M (ed): New Horizons in Neuropsychology. Amsterdam: Elsevier Science, 1994, pp 23-34
33. Smith CB, Crane AM, Kadekaro M, Agranoff BW, Sokoloff L: Stimulation of protein synthesis and glucose utilization in the hypoglossal nucleus induced by axotomy. J Neurosci 4:2489-2496, 1984
34. Smith CB, Deibler GE, Eng N, Schmidt K, Sokoloff L: Measurement of local cerebral protein synthesis in vivo: influence of recycling of amino acids derived from protein degradation. Proc Nat Acad Sci USA 85:9341-9345, 1988
35. Smith QR, Momma S, Aoyagi M, Rapoport SI: Kinetics of neutral amino acid transport across the blood-brain barrier. J Neurochem 49:1651-1658, 1987
36. Smith QR, Takasato Y: Kinetics of amino acid transport at the blood-brain barrier studied using an in situ brain perfusion technique. Ann NY Acad Sci 481:186-201, 1986
37. Soffietti R, Ruda R, Bradac GB, Schiffer D: PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas. Neurosurgery 43:1066-1073, 1998
38. Tovi M, Lilja A, Bergstrom M, Ericsson A, Bergstrom K, Hartman M: Delineation of gliomas with magnetic resonance imaging using Gd-DTPA in comparison with computed tomography and positron emission tomography. Acta Radiol 31:417-429, 1990
39. Tsuyuguchi N, Sunada I, Iwai Y, Yamanaka K, Tanaka K, Takami T, et al: Methionine positron emission tomography of recurrent metastatic brain tumor and radiation necrosis after stereotactic radiosurgery: is a differential diagnosis possible? J Neurosurg 98:1056-1064, 2003
40. Wester HJ, Herz M, Weber W, Heiss P, Senekowitsch-Schmidtke R, Schwaiger M, et al: Synthesis and radiopharmacology of O-(2-[18F]fluoroethyl)-L-tyrosine for tumor imaging. J Nucl Med 40:205-212, 1999
41. Willemsen AT, van Waarde A, Paans AM, Pruim J, Luurtsema G, Go KG, et al: In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. J Nucl Med 36:411-419, 1995